Semnur Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Semnur Pharmaceuticals, Inc. (SMNR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 130.00 thousand shares for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-08-15.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2025-08-15
- Semnur Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-03-31 was 130.00K shares, a 0.00% change year-over-year.
- Semnur Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-12-31 was 0.00 shares.
- Semnur Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-09-30 was 0.00 shares.
- Semnur Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-06-30 was 0.00 shares.
- Semnur Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 130.00K shares, a 0.00% change from fiscal 2023.
- Semnur Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 130.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2025-03-31 | 130.00K shares 10-Q · filed 2025-08-15 | 130.00K shares derived: sum of 2 quarters · filed 2025-08-15 | 130.00K shares derived: sum of 3 quarters · filed 2025-08-15 | 130.00K shares derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | 0.00 shares derived: sum of 2 quarters · filed 2025-04-02 | 0.00 shares derived: sum of 3 quarters · filed 2025-04-02 | 130.00K shares 10-K · filed 2025-04-02 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-19 | 130.00K shares 10-Q · filed 2024-11-19 | 130.00K shares derived: sum of 4 quarters · filed 2024-11-19 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | 130.00K shares 10-Q · filed 2024-08-19 | 130.00K shares derived: sum of 3 quarters · filed 2024-08-19 | 130.00K shares derived: sum of 4 quarters · filed 2024-08-19 |
| 2024-03-31 | 130.00K shares 10-Q · filed 2024-05-22 | 130.00K shares derived: sum of 2 quarters · filed 2024-05-22 | 130.00K shares derived: sum of 3 quarters · filed 2024-05-22 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 0.00 shares derived: sum of 2 quarters · filed 2024-04-01 | 130.00K shares 10-K · filed 2024-04-01 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 130.00K shares 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | 130.00K shares 10-Q · filed 2023-08-15 |